Table of Contents
ISRN Cell Biology
Volume 2012, Article ID 587259, 11 pages
http://dx.doi.org/10.5402/2012/587259
Review Article

Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer

Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA

Received 8 October 2012; Accepted 30 October 2012

Academic Editors: D. Arnoult and I. K. Koutna

Copyright © 2012 Dan G. Duda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • Dan G. Duda, “Biomarkers of Response and Resistance to Anti-angiogenic Treatment,” Angiogenesis Modulations in Health and Disease, pp. 181–198, 2013. View at Publisher · View at Google Scholar
  • Elham Mohit, and Sima Rafati, “Biological delivery approaches for gene therapy: Strategies to potentiate efficacy and enhance specificity,” Molecular Immunology, vol. 56, no. 4, pp. 599–611, 2013. View at Publisher · View at Google Scholar
  • Jan Trost Jorgensen, “Companion Diagnostics in Oncology - Current Status and Future Aspects,” Oncology, vol. 85, no. 1, pp. 59–68, 2013. View at Publisher · View at Google Scholar
  • Christian M. Becker, Mario Valenzano Menada, Matteo Morotti, and Simone Ferrero, “Targeting tyrosine-kinases in ovarian cancer,” Expert Opinion On Investigational Drugs, vol. 22, no. 10, pp. 1265–1279, 2013. View at Publisher · View at Google Scholar
  • Cathy C. Zhang, Zhengming Yan, Anand Giddabasappa, Patrick B. Lappin, Cory L. Painter, Qin Zhang, Gang Li, James Goodman, Brett Simmons, Bernadette Pascual, Joseph Lee, Ted Levkoff, Tim Nichols, and Zhiyong Xie, “Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib,” Cancer Medicine, 2014. View at Publisher · View at Google Scholar
  • Ai-Chung Mar, Chun-Ho Chu, Hui-Ju Lee, Chia-Wen Chien, Jing-Jy Cheng, Shung-Haur Yang, Jeng-Kai Jiang, and Te-Chang Lee, “Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cell,” Journal Of Biological Chemistry, vol. 290, no. 36, pp. 22212–22224, 2015. View at Publisher · View at Google Scholar
  • Beverly L. Falcon, Sudhakar Chintharlapalli, Mark T. Uhlik, and Bronislaw Pytowski, “Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents,” Pharmacology & Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Lipika Goyal, Hui Zheng, Matthew B. Yurgelun, Thomas A. Abrams, Jill N. Allen, James M. Cleary, Michelle Knowles, Eileen Regan, Amanda Reardon, Anna Khachatryan, Rakesh K. Jain, Valentina Nardi, Darrell R. Borger, Dan G. Duda, and Andrew X. Zhu, “A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma,” Cancer, 2017. View at Publisher · View at Google Scholar
  • Nunzia Caporarello, Melania Olivieri, Mario Salmeri, Carmelina Daniela Anfuso, Gabriella Lupo, Martina Cristaldi, and Maria Teresa Cambria, “Classical VEGF, Notch and Ang Signalling in cancer angiogenesis, alternative approaches and future directions (review),” Molecular Medicine Reports, vol. 16, no. 4, pp. 4393–4402, 2017. View at Publisher · View at Google Scholar
  • Anna Machoń-Grecka, Michał Dobrakowski, Aleksandra Kasperczyk, Ewa Birkner, Tomasz Pryzwan, and Sławomir Kasperczyk, “The effect of subacute lead exposure on selected blood inflammatory biomarkers and angiogenetic factors,” Journal of Occupational Health, vol. 60, no. 5, pp. 369–375, 2018. View at Publisher · View at Google Scholar
  • Karima El Alaoui-Lasmaili, and Béatrice Faivre, “Antiangiogenic therapy: markers of response, “normalization” and resistance,” Critical Reviews in Oncology/Hematology, 2018. View at Publisher · View at Google Scholar
  • Michalis Mastri, Amanda Tracz, Christina R. Lee, Melissa Dolan, Kristopher Attwood, James G. Christensen, Song Liu, and John M.L. Ebos, “A Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy Withdrawal,” Cell Reports, vol. 25, no. 13, pp. 3706–3720.e8, 2018. View at Publisher · View at Google Scholar
  • Qi Li, Xiaoxi Kan, Jie Yin, Lidong Sun, Yajie Wang, Yujie Li, Qing Yang, Hongbin Xiao, Ying Chen, Xiaogang Weng, Weiyan Cai, and Xiaoxin Zhu, “Chamaejasmine B Induces the Anergy of Vascular Endothelial Cells to VEGFA Pro-angiogenic Signal by Autophagic Regulation of VEGFR2 in Breast Cancer,” Frontiers in Pharmacology, vol. 8, 2018. View at Publisher · View at Google Scholar
  • van Mackelenbergh, Stroes, Spijker, van Eijck, Wilmink, Bijlsma, and van Laarhoven, “Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis,” Cancers, vol. 11, no. 5, pp. 588, 2019. View at Publisher · View at Google Scholar